Inventor · disambiguated record
Rajneesh Taneja
Also filed as: TANEJA RAJNEESH
9 granted patents·38 pending applications·23 citations·filing 2001–2022
84Inventor score
Files withTANEJA RAJNEESH13TAP PHARMACEUTICAL PROD INC4GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC3TAKEDA PHARMACEUTICALS USA INC3TAKEDA PHARMACEUTICALS CO2
Top patents by PatentIndex Score
47 records- 0186US9102666B2Methods and drug products for treating Alzheimer's diseaseROSES ALLEN D·Filed 2012·Granted Aug 11, 2015·8 cites·24 claims
- 0285US9724339B2Methods and drug products for treating alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 8, 2017·4 cites·27 claims
- 0380US8461187B2Multiple PPI dosage formTANEJA RAJNEESH·Filed 2005·Granted Jun 11, 2013·8 cites·19 claims
- 0472US9238029B2Multiple PPI dosage formTAKEDA PHARMACEUTICALS USA INC·Filed 2013·Granted Jan 19, 2016·2 cites·22 claims
- 0571US11179375B2Methods and drug products for treating Alzheimer's diseaseZINFANDEL PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·0 cites·7 claims
- 0670US2010004291A1Liquid dosage forms of non-enterically coated acid-labile drugsTANEJA RAJNEESH·Filed 2009·Application pending·0 cites
- 0766US2009075950A1Dosage Forms Containing A PPI, NSAID And A BufferTAKEDA PHARMACEUTICALS NORTH A·Filed 2008·Application pending·0 cites
- 0864US2008274200A1Dose titratable liquid dosage forms of acid labile drugsTAP PHARMACEUTICAL PRODUCTS·Filed 2008·Application pending·0 cites
- 0961US2007243251A1Dosage Forms Containing A PPI, NSAID, and BufferTANEJA RAJNEESH·Filed 2007·Application pending·0 cites
- 1061US2007232548A1Enhancement of Endogenous Gonadotropin ProductionTANEJA RAJNEESH·Filed 2007·Application pending·0 cites
- 1160US2009220621A1Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combinationTANEJA RAJNEESH·Filed 2009·Application pending·0 cites
- 1259US2010086572A1Rational ppi dosage formsTANEJA RAJNEESH·Filed 2009·Application pending·0 cites
- 1358US2005113337A1Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithinTAP PHARMACEUTICAL PROD INC·Filed 2004·Application pending·0 cites
- 1457US2010234430A1Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environmentsTANEJA RAJNEESH·Filed 2009·Application pending·0 cites
- 1556US2024199639A1Pretomanid amorphous formGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2022·Application pending·0 cites
- 1656US2017319565A1Methods and drug products for treating alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 1755US2002192299A1Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combinationFiled 2001·Application pending·0 cites
- 1855US2009074863A1Dosage Forms Containing A PPI, NSAID And A BufferTAKEDA PHARMACEUTICALS NORTH A·Filed 2008·Application pending·0 cites
- 1955US2004082618A1Liquid dosage forms of acid labile drugsFiled 2003·Application pending·0 cites
- 2055US2004081700A1Dose titratable liquid dosage forms of acid labile drugsFiled 2003·Application pending·0 cites
- 2155US2012142737A1Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combinationTANEJA RAJNEESH·Filed 2011·Application pending·0 cites
- 2254US2004002445A1Enhancement of endogenous gonadotropin productionFiled 2003·Application pending·0 cites
- 2354US2008292710A1Liquid Dosage Forms Of Acid Labile DrugsTAP PHARMACEUTICAL PROD INC·Filed 2008·Application pending·0 cites
- 2451US2003060451A1Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithinFiled 2002·Application pending·0 cites
- 2551US2023310276A1Methods of preparing modified dosage forms and related componentsGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2021·Application pending·0 cites
- 2650US6827208B2Packaging system for separately storing and dispensing together separate medication componentsTAP PHARMACEUTICAL PROD INC·Filed 2002·Granted Dec 7, 2004·1 cites·24 claims
- 2750US2004131676A1Dosage forms containing a PPI, NSAID, and bufferFiled 2003·Application pending·0 cites
- 2850US2004081671A1Liquid dosage forms of non-enterically coated acid-labile drugsFiled 2003·Application pending·0 cites
- 2949US9889152B2Multiple PPI dosage formTAKEDA PHARMACEUTICALS USA INC·Filed 2015·Granted Feb 13, 2018·0 cites·23 claims
- 3048US2012252848A1Liquid dosage forms of non-enterically coated acid-labile drugsTANEJA RAJNEESH·Filed 2012·Application pending·0 cites
- 3147US2025268832A1Pretomanid CompositionsGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2020·Application pending·0 cites
- 3247US2011180448A1Packaging system for separately storing and dispensing together separate medication componentsTANEJA RAJNEESH·Filed 2010·Application pending·0 cites
- 3346US2003164380A1Packaging system for separately storing and dispensing together separate medication componentsFiled 2002·Application pending·0 cites
- 3445US2008050444A1Pharmaceutical compositions of ilaparazoleTANEJA RAJNEESH·Filed 2006·Application pending·0 cites
- 3545US2004121004A1Dosage forms containing a PPI, NSAID, and bufferFiled 2002·Application pending·0 cites
- 3644US2003235628A1Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environmentsFiled 2001·Application pending·0 cites
- 3744US2003111380A1Packaging system for separately storing and dispensing together separate medication componentsFiled 2001·Application pending·0 cites
- 3844US2003111492A1Packaging system for separately storing and dispensing together separate medication componentsFiled 2001·Application pending·0 cites
- 3943US2009042887A1Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory AgentsTAP PHARMACEUTICAL PROD INC·Filed 2008·Application pending·0 cites
- 4042US2003111479A1Packaging system for separately storing and dispensing together separate medication componentsTANEJA RAJNEESH·Filed 2001·Application pending·0 cites
- 4141US2003168376A1Packaging system for separately storing and dispensing together separate medication componentsFiled 2002·Application pending·0 cites
- 4240US2017348231A1COMPOSITION AND METHOD FOR BUCCAL ADMINISTRATION OF GnRH AGONISTSNHTherapeutics INC·Filed 2016·Application pending·0 cites
- 4338US9248119B2Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitorsTANEJA RAJNEESH·Filed 2011·Granted Feb 2, 2016·0 cites·30 claims
- 4438US2004006109A1Liquid dosage forms of non-enterically coated acid-labile drugsFiled 2002·Application pending·0 cites
- 4538US2003186892A1Enhancement of endogenous gonadotropin productionFiled 2002·Application pending·0 cites
- 4638US2004005362A1Liquid dosage forms of acid labile drugsFiled 2002·Application pending·0 cites
- 4737US9937157B2Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2016·Granted Apr 10, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Rajneesh Taneja files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →